Publicação
DIAGNOSTIC APPROACH TO ARTERIAL HYPERTENSION OF SUSPECTED SECONDARY CAUSE IN PRIMARY HEALTH CARE - HYPERTENSION OF ENDOCRINE CAUSE
| Resumo: | Endocrine diseases are frequent causes of secondary hypertension, and primary hyperaldosteronism is the most common endocrine cause of hypertension. Unlike other endocrine diseases, primary hyperaldosteronism has no typical phenotypic characteristics, and is often misdiagnosed as essential hypertension. It is, however, associated with much higher morbidity and mortality than essential hypertension. Targeted therapy for hyperaldosteronism allows for the cure or significant improvement of hypertension; therefore, its screening is currently recommended in most patients with suspicion of secondary hypertension, starting at the primary health care level. However, primary hyperaldosteronism continues to be screened in only a minority of patients with hypertension. Thus, it is essential to underline the importance of screening and to simplify its approach in clinical practice. To this end, we propose a simplified algorithm to increase the diagnosis and treatment of primary hyperaldosteronism in Portugal, and to reduce its negative impact on patients and health costs. |
|---|---|
| Autores principais: | Carreira, Ana |
| Outros Autores: | Mateus-Pinheiro, António; Silva, Rita; Melo, Miguel; Coutinho-Teixeira, Vítor; Ferreira, Rogério |
| Assunto: | hipertensão arterial secundária hiperaldosteronismo primário cuidados de saúde primários rastreio |
| Ano: | 2024 |
| País: | Portugal |
| Tipo de documento: | artigo |
| Tipo de acesso: | unknown |
| Instituição associada: | Sociedade Portuguesa de Hipertensão |
| Idioma: | português |
| Origem: | Revista Portuguesa de Hipertensão e Risco Cardiovascular |
| Resumo: | Endocrine diseases are frequent causes of secondary hypertension, and primary hyperaldosteronism is the most common endocrine cause of hypertension. Unlike other endocrine diseases, primary hyperaldosteronism has no typical phenotypic characteristics, and is often misdiagnosed as essential hypertension. It is, however, associated with much higher morbidity and mortality than essential hypertension. Targeted therapy for hyperaldosteronism allows for the cure or significant improvement of hypertension; therefore, its screening is currently recommended in most patients with suspicion of secondary hypertension, starting at the primary health care level. However, primary hyperaldosteronism continues to be screened in only a minority of patients with hypertension. Thus, it is essential to underline the importance of screening and to simplify its approach in clinical practice. To this end, we propose a simplified algorithm to increase the diagnosis and treatment of primary hyperaldosteronism in Portugal, and to reduce its negative impact on patients and health costs. |
|---|
Atividades financiadas
Não foram encontrados projetos financiados.